Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Beovu
Pharma
Novartis targets Xiidra in eye disease asset sale: Bloomberg
Novartis has tapped an adviser to start selling some ophthalmology assets, Bloomberg reports. But not all Novartis eye drugs are up for sale.
Angus Liu
Mar 14, 2023 10:22am
Performance slump takes toll on Novartis' CEO's 2022 payout
Mar 8, 2023 9:33am
Novartis targets eye, respiratory units for sell-offs: Bloomberg
Nov 16, 2022 10:48am
EMA expands nods for BMS, Eli Lilly, Novartis drugs
Feb 25, 2022 11:42am
Roche pharma CEO Anderson talks up Vabysmo's strong launch plans
Feb 9, 2022 9:51am
Regeneron's higher dose Eylea looks safe in phase 2
Aug 24, 2021 11:11am
